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Cistanches Herba (family Orobanchaceae), commonly known as “desert ginseng” or
Rou Cong Rong, is a global genus and commonly used for its neuroprotective,
immunomodulatory, anti-oxidative, kidney impotence, laxative, anti-inflammatory,
hepatoprotective, anti-bacterial, anti-viral, and anti-tumor effects in traditional herbal
formulations in North Africa, Arabic, and Asian countries. The major bioactive compound
present in this plant is phenylethanoid glycosides. In recent years, there has been great
important in scientific investigation of the neuropharmacological effects of the bioactive
compounds. The in vitro and in vivo studies suggests these compounds demonstrate
neuropharmacological activities against a wide range of complex nervous system
diseases which occurs through different mechanisms include improving immunity
function and kidney aging, anti-lipid peroxidation, scavenging free radical, inducing
the activation of caspase-3 and caspase-8. This review aims to summaries the
various neuropharmacological effects and mechanisms of Cistanches Herba extracts
and related compounds, including its efficacy as a cure for Alzheimer’s disease and
Parkinson’s disease with reference to the published literature. Which provides guidance
for further research on the clinical application of Cistanches Herba.
Keywords: Cistanches Herba, neuropharmacological effect, Alzheimer’s disease, Parkinson’s disease, review
INTRODUCTION
Cistanches Herba, the dried stem of Cistanches species Cistanche deserticola Y.C.Ma (Figure 1)
and Cistanche tubulosa (Schenk) Wight, is recorded in the Chinese Pharmacopeia (Committee,
2015). Other non-official species, such as C. sinensis Beck and C. salsa (C. A. Mey) Beck, are also
used as Cistanches Herba in certain regions of China due to resource shortage. Cistanches Herba is
one of the most valuable herbal drugs in traditional Chinese medicine, which supplements kidney
functions, boosts the essence of blood, and moistens the large intestines to free stool (Medicine,
2005). Therefore, it is called “desert ginseng” in China because of the excellent medicinal functions
and nourishing effects (Wang et al., 2012). Cistanches Herba, a global genus of holoparasitic desert
plant, which is primarily endemic in North Africa, Arabic, and Asian countries (Nan et al., 2013).
The primary producing areas of Cistanches Herba in China are Inner Mongolia and the provinces
of Xinjiang, Gansu and Qinghai.
Several chemical groups were isolated from Cistanches Herba, including PhGs (Figure 1),
lignans, iridoids, and polysaccharides (Chen et al., 2013). Pharmacological studies demonstrated
Abbreviations: Aβ, β-amyloid; AD, Alzheimer’s disease; GSH-Px, glutathione peroxidase; MDA, malondialdehyde; PD,
Parkinson’s disease; PhGs, phenylethanoid glycosides; RNS, reactive nitrogen species; ROS, reactive oxygen species; SOD,
superoxide dismutase.
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that Cistanches Herba exhibits neuroprotective, kidney
impotence, laxative, anti-inflammatory, hepatoprotective,
immunomodulatory, anti-oxidative, anti-bacterial, anti-viral,
and anti-tumor effects (Hu and Feng, 2012). And our previous
studies have distinguished Cistanches Herba from different
geographic origins using a combination of DNA barcoding and
UPLC-Q-TOF/MS technology.
The Consumer Price Indexdatabase of China reports that 58
drugs from 12 different groups, including glycosides of Cistanche
capsules and compound Cistanche Yizhicapsules, are authorized
for the treatment of AD. Cistanches Herba wine and tea are
produced in Alashan, Inner Mongolia, China, which might assist
in Runchang catharsis and enhance the immune, endocrine
regulation, and anti-aging systems of the body. Boschnalosides
used as a therapeutic agent in Japan to treat sexual dysfunction
and amnesia, and echinacoside is used in healthcare products in
the United States to improve immunity (Cheng et al., 2005).
Some researchers recently focused on the neuroprotective
effects of Cistanches Herba, but these effects have not been studied
thoroughly (Table 1). This review presents and analyzes recent
developments in the neuropharmacology ofCistanches Herba and
provides a reference for the further study and clinical application
of this medicinal plant.
RELATED LITERATURE ANALYSIS
Cistanches Herba medicines have a long history of practical
use, but scientists worldwide only began to disclose their
chemical composition in the1980s. Figure 2 shows an analysis
of the related literature. The cumulative histogram shows
the number of studies increased over time, and the Chinese
literature occupies the greatest proportion, which reveals
the potential research value of Cistanches Herba. Figure 2A
shows that the neuropharmacology related literature occupies
the largest proportion of the nine areas of pharmacology,
and this topic has become the most important area for
research. Figure 2B exhibits the chemical research diversity
of Cistanches Herba, with a substantial proportion of research
on content determination. Further research may focus on
neuropharmacology and component content.
TRADITIONAL USE AND
ETHNOPHARMACOLOGY
Cistanches Herba has a long history as a medicinal plant in
China and Japan because of its wide spectrum of pharmacological
activities. It is commonly called Rou Cong Rong in Chinese, and
it was first listed medicinal use as a tonic agent in the Chinese
Materia Medica Shen Nong’s Herbal Classic (Estern Han Dynasty)
2000 years ago, and later recorded in Yao Xing Lun in 1590.
The Compendium of Materia Medica (Ben Cao Gang Mu, 1619)
documented that Cistanches Herba invigorated the kidney to
treat kidney deficiencies and geriatric constipation strengthened
and nourished marrow and essence, protected semen, and
moistened dryness to relax the bowels. These properties were
also written in Ben Cao Hui Yan in 1619. A total of 200
medicinal books recorded the pharmacodynamics and use of
Cistanches Herba in Chinese history. Cistanches Herba ranks
first in Chinese traditional medicine to strengthen prescriptions,
which ranks second in anti-aging prescriptions at the same time,
FIGURE 1 | The Cistanches Herba growed in Alashan, Inner Mongolia, China; and the structures of two important phenylethanoid glycosides in
Cistanche Herba. (A) The original Cistanche deserticola Y. C. Ma; (B) The dry Cistanche deserticola Y. C. Ma; (C) Echinacoside; (D) Verbascoside.
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FIGURE 2 | Statistical analysis for published literatures of Cistanches Herba. (A) Pharmaceutical literatures analysis of Cistanches Herba; (B) Chemical
literatures analysis of Cistanches Herba.
behind Panax ginseng in past dynasties. Modern pharmacological
investigations demonstrated that Cistanches Herba was used as a
kidney-yang reinforcing Chinese medicinal tonic, but it is also
exhibits anti-aging, improves memory, and enhances immunity
effects (Table 1), which indicate that extracts or constituents
from Cistanches Herba have a promising future for the treatment
of diseases, particularly nervous system disorders. However,
systematic data on the pharmacological activities of this agent is
lacking. It is urgent and important to study the pharmacological
effects and mechanisms of Cistanches Herba deeply in the future.
PHARMACOLOGY
Anti-aging Properties
Aging is an inevitable process of life. This process involves a
series of degenerative changes in tissues and organ functions
with advancing age. Studies on aging and anti-aging medicines
have made significant progress in recent years. Therefore, anti-
aging drugs are a current and prominent issue in gerontology.
The aging process reflects a confluence of in vivo and in vitro
factors. Aging is closely related to type 2 diabetes, atherosclerosis,
and AD. Aging is also related to the decreased regeneration of
cells, viscera deficiency, increased free radicals, body poisoning,
and lack of rhythm when eating (Lopez-Otin et al., 2013).
Aging is an inevitable process, but delaying this process is now
possible.
Several historical Chinese herbal pharmacopeias describe
that Cistanches Herba possesses anti-aging properties. PhGs
and oligosaccharides are two types compounds isolated from
Cistanches Herba that are the main active ingredients of this
plant. In vivo studies established an aging mouse model caused by
D-galactose. The mice were divided into normal control, model,
Vitamin E and total glycoside groups, and all groups received
different doses of various materials. The results suggested that
the glycosides exhibited protective effects on the hippocampal
ultrastructure, and glycosides may play a role in the delay of
aging and the prevention and treatment of senile dementia via
anti-oxidation (Wang X. et al., 2015). Xu et al. investigated the
protective effect of Cistanches Herba alcohol extract on hepatic
mitochondria and established an aging rat model caused by
D-galactose. Rats were administered Cistanches Herba alcohol
extract for 6 weeks. The results indicated that Ca2+-ATP enzyme
activity was enhanced, and the MDA content in the hepatic
mitochondria was reduced. These results further suggested that
the Cistanches Herba alcohol extract effectively protected hepatic
mitochondria in the D-galactose aging rat model (Xu et al., 2007).
Xu and Liu (2008) examined the anti-aging effect of PhGs isolated
from Cistanches Herba. The results confirmed that the PhGs
improved learning and memory, exhibited antioxidant activity,
and boosted the immune system. The results also demonstrated
that the PhGs exhibited anti-aging effects via enhancement of
anti-oxidation. The mechanism may be related to the free radical
scavenging ability of PhGs. Polysaccharides of Cistanches Herba
exhibit the same function as PhGs on anti-aging (Xu et al.,
2008; Zhang et al., 2011). Zhang et al. (2014) also investigated
a Cistanches Herba extraction 2014 and found that this extract
extended life span. The results of studies on echinacoside and
acteoside suggest that these components exhibit positive anti-
aging effects (Zhang et al., 2008; Xie et al., 2009). Many studies of
anti-aging involve Cistanches Herba, but these works are limited
because the anti-aging mechanism is not known. There are three
possible pathways to anti-aging, including improving immunity
function and kidney aging, anti-lipid peroxidation. Immune
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theory of aging said that the decline of immune function is closely
related to the aging organism. Thus, the immune function of
the body can indirectly reflect the aging organism in a certain
extent. The raised index of thymus and spleen, increased content
of IFN-γin serum and decreased content of IL-6, increased
capacity of peritoneal macrophage phagocytic and lymphocyte
proliferation response always can improve the immunity aging,
and then delay the organism aging. The expression of p53 from
human fibroblastic cell down-regulated significantly in a dose
dependent manner after treatment with echinacoside, and which
may be correlated with the up-regulation of SIRT1. The PhGs
can scavenge different ROS, including. O−2 , H2O2 and ·OH,
effectively and protect DNA damage through scavenging ·OH. In
addition, the PhGs also can increase the content of RNS- NO, and
then reduce the lipid peroxidation. Therefore, the real effective
components of Cistanches Herba and what a role in anti-aging
are important and appealing future research directions.
Anti-oxidative and Anti-apoptotic Activity
Cistanches Herba exhibits anti-oxidative, free radical-scavenging
and anti-apoptotic activity via different mechanisms. Recent
studies demonstrated the anti-oxidant activity of Cistanches
Herba, particularly in the clearing of all types of free radicals
in vivo and in vitro, improvement in the activity of anti-
oxidant enzymes in the body, and inhibition of the formation
of lipid peroxide, MDA, and brown fat (Wang et al., 2001; Wu
and Fu, 2004; Luo et al., 2012; Song, 2013). Current studies
demonstrated that cell apoptosis or programmed cell death is
determined by heredity and is related to oxidation (Martin,
2011). Deng used the MTT assay to examine cell survival rate,
agarose gel electrophoresis of DNA, and flow cytometry to
detect cell apoptosis. The results suggested that the echinacoside
extracted from Cistanches Herba exhibited protective effects
on TNFα-induced SH-SY5Y cell apoptosis (Deng et al., 2005).
Nerve cell protection exhibits a close connection with the
reduction of active oxygen levels in cells, inhibition of caspasc-3
activity and maintenance of a high-energy state of mitochondrial
membrane potential. Bao et al. (2010) investigated an extract
of Cistanche tubulosa and discussed its anti-oxidant ability.
These researchers conducted an in vitro study to compare the
anti-oxidative properties of methanol and ethanol extracts. The
results suggested that the two extracts exhibited high anti-
oxidant ability, and 70% ethanol was the best extraction agent
of C. tubulosa to ensure improved anti-oxidant activity (Bao
et al., 2010). The PhGs from Cistanches Herba are considered the
effective ingredients for anti-oxidative and anti-apoptotic activity
in recent studies. The anti-oxidant mechanism is mainly related
to the radical-scavenging activity. PhGs compounds, which are
mostly provided with different amounts of phenolic hydroxyl,
can be used as hydrogen donor to reductive radicals, and then
reach to the purpose of radical scavenging. The Cistanches
Herba scavenge the free radicals mainly in two ways, including
directly involving in the removal of free radicals or blocking their
production and regulating the anti-oxidant enzymes related to
the free radical metabolism in vivo, such as SOD, CAT and GPX
(Ko and Leung, 2007). For another, the Glycosides of Cistanches
Herba can prevent the apoptosis of cerebellar granule neurons
by inhibiting the activities of caspase-3 and caspase-8. Therefore,
the good oxidation resistance and anti-aging ability of Cistanches
Herba may be applied to cosmetics. This application may be a
new research direction in the future.
Learning and Memory Enhancement
Learning and memory are advanced functions of the brain, and
these functions are important factors in determining intelligence.
Learning and memory impairment is a common symptom in
different types of encephalopathy, such as attention deficit and
hyperactivity disorder in childhood, adolescent chorea, lobar
atrophy disease, neurosis, senile cerebral arteriosclerosis, and
dementia. Medicinal research demonstrated that the impairment
of learning and memory is closely related to the impairment
of synaptic transmission in the brain and the metabolism of
neurotransmitters, other substances, and energy in the brain
(Chen, 1993). Modern pharmacological studies determined that
Cistanches Herba significantly improves learning and memory,
and PhGs are the active chemical ingredients of this effect.
Traditional Chinese medicine shows that learning and
memory dysfunction exists in the Yang deficiency model of the
spleen and kidney. Therefore, these two models are more suitable
for the study of tonics in traditional Chinese medicine. Gao
et al. (2005) examined the effects of Cistanches Herba glycosides
on the learning and memory of kidney Yang deficiency mice.
The results of this study demonstrated that the Yang deficiency
symptoms of each dose group improved, and the number of
animal deaths decreased significantly. However, the jumping
latency of each dose group after hydrocortisone administration
was significantly prolonged, and the number of errors during a
5-min period was reduced. Therefore, glycosides improved the
learning and memory of kidney Yang deficiency mice induced by
hydrocortisone and reduced the death rate of these animals (Gao
et al., 2005). The current researchers established a scopolamine-
induced learning and memory impairment mouse model to
investigate the effects of the PhGs of Cistanches Herba. The
results demonstrated that the PhGs of Cistanches Herba enhanced
learning and memory (Li, 2011; Liu et al., 2011). Choi et al. (2011)
also demonstrated that Cistanches Herba enhanced learning and
memory via the induction of nerve growth factor. Vary factors
related to cerebrovascular disease induce vascular dementia.
This condition is an acquired intelligence-damaging syndrome
of cognitive impairment, which is a primary type of senile
dementia. Ischemic cerebrovascular disease occurs frequently in
many cerebrovascular diseases induced by vascular dementia.
Traditional medicine and modern pharmacology demonstrated
that PhGs play an active role in neuroprotection (Feng et al.,
2013; Liu et al., 2013; Zhu et al., 2013; Zhang, 2014). The
reason why Cistanches Herba extract can improve learning and
memory is partly due to neuronal cell differentiation, neurite
outgrowth and presynaptic formation promoted. Cistanches
Herba also improved cognitive behavior related to memory
ability. Therefore, Cistanches Herba is a potential candidate for
cognitive enhancement owing to its action as a nerve growth
factor modulator. However, extensive research is necessary to
discover the neuroprotective mechanism deeply. Further studies
to determine the specific type of PhGs are expected to play
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a leading role in improving learning and addressing memory
impairment.
ANTI-NEURODEGENERATIVE DISEASES
Anti-Alzheimer’s Disease
Alois Alzheimer originally described AD in 1906 based on
his observations of amyloid plaques, neurofibrillary tangles,
and vascular anomalies during the autopsy of August Deter,
a patient who died with severe cognitive defects. AD is a
progressive neurodegenerative disorder that affected more than
30 million people worldwide in 2010 (Williams et al., 2011).
The pathogenesis of this disease is complex and not completely
understood. However, several potential causative factors were
proposed, including cholinergic neurons, Aβ toxicity, tau protein,
insulin, and free radical damage. Considerable attention was
devoted recently to inflammation, insulin, oxidative imbalance,
and gene mutation hypotheses (Verma et al., 2016) (Figure 3).
Numerous drugs reduce the symptoms of AD, but no cure
has been developed. Drugs that treat AD currently include
six major classes: cholinesterase inhibitors, NMDA receptor
antagonists, neurotrophic factors, drugs that promote nerve
cell metabolism, neuroprotective agents, and traditional Chinese
medicine (Deardorff and Grossberg, 2016).
Studies of traditional Chinese medicine suggest thatCistanches
Herba has positive effects on the treatment of AD. An in vitro
study of the effects ofCistanches Herba in quinolinic acid-reduced
AD mouse model determined that the content of MDA and
calciumin brain tissue was reduced, the activity of SOD and
GSH-Px improved, and the activity of acetylcholinesterase E and
the apoptosis rate of brain cells was depressed. These results
suggest that the glycosides of Cistanches Herba enhance learning
and memory and protect the brain from damage. The mechanism
may be related to the enhanced free removal of enzyme activity,
reduced lipid oxidation reaction, lower brain tissue calcium
content and the inhibition of apoptosis of brain cells induced by
QA (Liu et al., 2005). Liu et al. established an AD mouse model
in 2006 using a one-time microinjection of β-AP25−35, which
reduced β-AP deposition in the brain. Repeated administration
of glycosides of Cistanche for 10 days reduced the MDA content
and apoptosis rate of brain cells, improved SOD and GSH-Px,
weakened Bax expression, and enhanced Bc-l2 expression. Bax
weakening and enhanced Bc-l2 may induce the enhanced free
removal of enzyme activity, reduced lipid oxidation reaction and
inhibition of apoptosis of brain cells (Liu et al., 2006). Luo et al.
also used the AD mouse model induced by the subcutaneous
injection of aluminum chloride and demonstrated that Cistanches
Herba enhanced learning and memory. The mechanism is
closely connected with anti-oxidation (Luo et al., 2007). The
previously mentioned models of AD were established using
different methods. However, the results consistently illustrated
that Cistanches Herba glycosides significantly improved learning
and memory impairments in the brain. Studies also suggested
that the underlying mechanism of these glycosides related to
anti-oxidative actions, enhancement of free radical scavenging
activity and inhibition of brain cell apoptosis. Luo, Gao and Wu
et al. (Luo et al., 2010, 2013; Ying et al., 2014) conducted similar
experiments and revealed that various components of Cistanches
Herba, including glycosides, extract, echinacoside, and acteoside,
exhibit active anti-AD effects to varying degrees (Supplementary
Table S1). The mechanisms related to anti-AD including free
radical scavenging activity enhancement, lipid peroxidation
improvement, apoptosis inhibition, the production of active
FIGURE 3 | Different pathogenesis hypothesis of Alzheimer’s disease. (A) Tau hypothesis; (B) Cholinergic hypothesis; (C) Free radical damage hypothesis;
(D) Inflammation hypothesis; (E) Amyloid cascade hypothesis.
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oxygen decrease and apoptotic signal pathway regulating.
Additionally, previous research have studied the mechanism
from the point of proteomics that the echinacoside can reduce
the over-expression of biliverdin reductase B, which suggest
that the anti-oxidative activity of echinacoside can reduce the
increasing of biliverdin reductase B induced by oxidative stress
and protect the dopaminergic neurons from oxidative stress
injury. However, the real cause of AD and the resistance
mechanism of Cistanches Herba need us spend more efforts to
explore.
Anti-Parkinson’s Disease
Parkinson’s disease is a neurodegenerative disorder that is
characterized by the selective degeneration of dopaminergic
neurons in the substantia nigra pars compacta and a consequent
reduction in striatal dopamine levels in the brain. PD is one
of the most common diseases in the elderly. The clinical
manifestations of this disease include hypokinesia, skeletal
muscle tension, and resting muscle tremor. British doctor
James Ba Jinsen (Parkinson) first described this unusual
group of symptoms in 1817, and the disorder was eventually
named after him. PD is second only to AD as the most
common degenerative disease, which exhibits an incidence rate
of 1–2% of people aged 65 years and older and increases
with advancing age. Neuropathological hallmarks of PD were
described extensively, but its etiology is not defined. Genetic
and environmental factors may play a pivotal role in the
causes of PD. Previous studies demonstrated that oxidative
stress, a cellular dysfunction between the production and
scavenging of free radicals, was the primary mechanism of
the associated with neuronal death (Liu et al., 2014; Wen
and Wang, 2014; Huang, 2015; Lin et al., 2015; Ma, 2015;
Ou et al., 2015; Peng and Bai, 2015; Wen and Xu, 2015).
The most extensively used of PD mouse model is produced
via the systemic administration of the neurotoxin MPTP.
MPTP is switched on by monoamine oxidase B within non-
dopaminergic cells, predominantly glial cells, to its active
metabolite 1-methyl-4-phenylpyridinium (MPP+), which enters
dopaminergic neurons through the dopamine transporter. The
accumulation of MPP+ in the substantia nigra pars compacta
neurons inhibits complex of the mitochondrial electron transport
chain, which ultimately leads to cell death (Geng et al., 2007).
The in vivo study demonstrated that campneoide and tubuloside
B of Cistanches Herba protected neurons from MPP+-induced
apoptosis (Pu et al., 2001; Sheng et al., 2002). Geng et al.
(2004) investigated the neuroprotective effects of PhGs from
Cistanches salsa against MPTP-induced dopaminergic toxicity
in C57 mice and demonstrated that echinacoside improved
the behavioral defects of PD mice. The PhGs could be
attractive candidates against some typical neurological diseases,
such as PD. Chen et al. investigated the echinacoside of
Cistanches salsa and demonstrated that this natural phenol
may be useful in PD prevention and treatment (Chen et al.,
2007).
Parkinson’s disease has received significant attention, but this
disease is not fully understood. Cure is not available because of
the complex etiology and pathogenesis of PD, and the therapeutic
tool for this disease is primarily drug treatment. However, long-
term drug use likely results in serious side effects. Therefore,
a treatment that combines Chinese and Western medicines is
important. Further research on PD pathogenesis and therapeutic
tool is necessary to reduce the side effects of drugs and obtain
good treatment effects.
TOXICOLOGY
Cistanches Herba was commonly considered a safe traditional
medicine in China for 1000 of years (Shen Nong’s Herbal Classic).
Common adverse clinical reactions of preparations of Cistanches
Herba are mild and include nausea and vomiting, abdominal
pain, and dizziness. However, recent investigations indicated
that extracts of Cistanches Herba exhibit no obvious toxicity
(Peng et al., 2011; Jiang et al., 2013; Huang et al., 2014; Qin
et al., 2015). Toxicology may be a new direction of future
research.
DISCUSSION AND FUTURE
PERSPECTIVES
Cistanches Herba has been the increasing interest subject in
recent years, and many traditional uses have been validated
by pharmacological studies. Previous animal investigations and
in vitro studies of plant preparations revealed that Cistanches
Herba possesses a significant neuroprotective effect. Cistanches
Herba extract and its constituents not only exhibit positive
activities in AD and PD treatments but also against other
diseases and conditions, such as aging, and learning and
memory impairments. These results support the considerably
high value of Cistanches Herba, which plays a significant
role in clinical application and provides a potential basis for
new drugs against nervous system diseases. Pharmacological
analysis of Cistanches Herba extracts and related compounds
also provided new insights into the treatment of nervous system
diseases.
Previous researches have investigated the pharmacokinetics
and bioavailability of PhGs. In Jia’s study (Jia et al., 2006),
the echinacoside in rat serum was tested in four kinds
situation. Results showed that the echinacoside in biosamples was
susceptible to degradation at a higher temperature during the
whole process and the operation must be carried out at lower
temperature. The absorption of echinacoside was extaemely
fast (Tmax, 15 min) in rats after intragastric administration
(100 mg/kg). However, the serum concentration maximum was
very low (Cmax, 612.2 ± 320.4 ng/mL). The elimination was
fast after intragastric administration (T1/2, 74.4min). And on
the other hand, the distribution and elimination of echinacoside
were extremely fast in rats (t1/2α, 12.4min; t1/2β, 41.0min) after
intravenous administration. The bioavailability of echinacoside
in rat was very low, which was consistent with the result in
Matthias’ report (Matthias et al., 2004). Wu et al. (2006) explored
the pharmacokinetics of acteoside in Cistanches Herba in rats.
The results showed that acteoside was evenly distributed in brain
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tissues which was about 0.45–0.68% of that in plasma after 15 min
of acteoside intragastric administration. The bioavailability of
acteoside and echinacoside were both very low, which always
can through the blood brain barrier and reach the brain. The
wide dosage range listed in tables may be associated with the low
bioavailability. To improve the bioavailability of PhGs, numerous
approaches may be undertaken, including the use of liposomal
PhGs, PhGs nanoparticles, the use of PhGs phospholipid complex
and the use of structural analogs of PhGs. Further study needs
to be carried out to increase the bioavailability and elucidate the
human absorption mechanism.
In this review we can see that most neuropharmacological
effects have closely relationships with the antioxidant activity of
Cistanches Herba. Thus the further study of antioxidant is needed
urgently. The development and discovery of a new drug from
Cistanches Herba requires much more detailed investigations of
its pharmacological mechanism, pharmacokinetic and clinical
use, particularly at the molecular level, despite continued
progress on various aspects of this plant. Further studies on
Cistanches Herba will address an urgent medical need through the
development of efficacious treatments for nervous system disease.
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